These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27643474)

  • 1. Blood oozing: A cause of life-threatening bleeding without overt source after transcatheter aortic valve replacement.
    Tarantini G; Mojoli M; Barioli A; Battistel M; Généreux P
    Int J Cardiol; 2016 Dec; 224():107-111. PubMed ID: 27643474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
    Dangas GD; Lefèvre T; Kupatt C; Tchetche D; Schäfer U; Dumonteil N; Webb JG; Colombo A; Windecker S; Ten Berg JM; Hildick-Smith D; Mehran R; Boekstegers P; Linke A; Tron C; Van Belle E; Asgar AW; Fach A; Jeger R; Sardella G; Hink HU; Husser O; Grube E; Deliargyris EN; Lechthaler I; Bernstein D; Wijngaard P; Anthopoulos P; Hengstenberg C;
    J Am Coll Cardiol; 2015 Dec; 66(25):2860-2868. PubMed ID: 26477635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Outcomes After Transcatheter Aortic Valve Replacement: A POPular TAVI Subanalysis.
    van Bergeijk KH; van Ginkel DJ; Brouwer J; Nijenhuis VJ; van der Werf HW; van den Heuvel AFM; Voors AA; Wykrzykowska JJ; Ten Berg JM
    JACC Cardiovasc Interv; 2023 May; 16(9):1095-1102. PubMed ID: 37164609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Stent Graft Implantation for Treatment of Access Site Bleeding After Transfemoral Transcatheter Aortic Valve Replacement.
    Segal A; Flugelman MY; Khader N; Rubinshtein R; Lavi I; Karmeli R; Jubran A; Shiran A; Jaffe R
    Am J Cardiol; 2017 Aug; 120(3):456-460. PubMed ID: 28583682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.
    Généreux P; Cohen DJ; Mack M; Rodes-Cabau J; Yadav M; Xu K; Parvataneni R; Hahn R; Kodali SK; Webb JG; Leon MB
    J Am Coll Cardiol; 2014 Dec; 64(24):2605-2615. PubMed ID: 25524339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Antithrombotic Therapy in TAVR.
    O'Malley RG; Mahaffey KW; Fearon WF
    Curr Cardiol Rep; 2017 May; 19(5):41. PubMed ID: 28391560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Two-Dimensional Ultrasonographically Guided Access to Reduce Access-Related Complications for Transcatheter Aortic Valve Replacement.
    Elbaz-Greener G; Zivkovic N; Arbel Y; Radhakrishnan S; Fremes SE; Wijeysundera HC
    Can J Cardiol; 2017 Jul; 33(7):918-924. PubMed ID: 28579163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial Cutaneous Femoral Fistulous Tract Closure Using Surgiflo Hemostatic Matrix: A Novel Adjunct for Post-TAVR Access-Site Management.
    Gajo E; Iftikhar O; Pearson PJ; Feldman T; Guerrero M; Levisay J; Salinger MH
    J Invasive Cardiol; 2017 Aug; 29(8):277-279. PubMed ID: 28756421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Bleeding Associated With Very Early Subclinical Valve Thrombosis After Transcatheter Aortic Valve Replacement.
    Ferrante G; Rossi A; Corrada E; Reggi A; Regazzoli D; Reimers B; Pagnotta P
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1623-1624. PubMed ID: 31377274
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of an ePTFE-covered nitinol self-expanding stent graft for the treatment off pre-closure device failure during transcatheter aortic valve replacement.
    Steinvil A; Bernardo N; Rogers T; Koifman E; Buchanan K; Alraies MC; Shults C; Torguson R; Okubagzi PG; Pichard AD; Satler LF; Ben-Dor I; Waksman R
    Cardiovasc Revasc Med; 2017 Mar; 18(2):128-132. PubMed ID: 27865711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
    Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
    Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year outcomes after transcatheter or surgical aortic-valve replacement.
    Kodali SK; Williams MR; Smith CR; Svensson LG; Webb JG; Makkar RR; Fontana GP; Dewey TM; Thourani VH; Pichard AD; Fischbein M; Szeto WY; Lim S; Greason KL; Teirstein PS; Malaisrie SC; Douglas PS; Hahn RT; Whisenant B; Zajarias A; Wang D; Akin JJ; Anderson WN; Leon MB;
    N Engl J Med; 2012 May; 366(18):1686-95. PubMed ID: 22443479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial.
    Collet JP; Berti S; Cequier A; Van Belle E; Lefevre T; Leprince P; Neumann FJ; Vicaut E; Montalescot G
    Am Heart J; 2018 Jun; 200():44-50. PubMed ID: 29898848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.
    Stachon P; Kaier K; Milde S; Pache G; Sorg S; Siepe M; von zur Mühlen C; Zirlik A; Beyersdorf F; Langer M; Zehender M; Bode C; Reinöhl J
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):731-7. PubMed ID: 25759083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.
    Kapadia SR; Tuzcu EM; Makkar RR; Svensson LG; Agarwal S; Kodali S; Fontana GP; Webb JG; Mack M; Thourani VH; Babaliaros VC; Herrmann HC; Szeto W; Pichard AD; Williams MR; Anderson WN; Akin JJ; Miller DC; Smith CR; Leon MB
    Circulation; 2014 Oct; 130(17):1483-92. PubMed ID: 25205802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kalich BA; Allender JE; Hollis IB
    Pharmacotherapy; 2018 Jan; 38(1):122-138. PubMed ID: 29121410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.
    Gleason TG; Schindler JT; Adams DH; Reardon MJ; Kleiman NS; Caplan LR; Conte JV; Deeb GM; Hughes GC; Chenoweth S; Popma JJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):85-96. PubMed ID: 27085389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balloon Versus Computed Tomography Sizing of the Aortic Annulus for Transcatheter Aortic Valve Replacement and the Impact of Left Ventricular Outflow Tract Calcification and Morphology on Sizing.
    Condado JF; Lerakis S; Stewart J; Jensen H; Henry TS; Ko SM; Stillman A; Rajaei MH; Mavromatis K; Devireddy C; Sarin E; Leshnower B; Guyton R; Kaebnick B; Thourani VH; Block PC; Babaliaros V
    J Invasive Cardiol; 2016 Jul; 28(7):295-304. PubMed ID: 27101969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Telila T; Akintoye E; Ando T; Merid O; Mallikethi-Reddy S; Briasoulis A; Grines C; Afonso L
    Am J Cardiol; 2017 Jul; 120(2):300-303. PubMed ID: 28576265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.